A critical role of nonclassical MHC in tumor immune evasion in the amphibian Xenopus model

Carcinogenesis

Volumn 35, Issue 8, 2014, Pages 1807-1813

  Haynes Gilmore, Nikesha ^a   Banach, Maureen ^a   Edholm, Eva Stina ^a   Lord, Edith ^a   Robert, Jacques ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Comparative immunology; MHC class I like; Tumor immunity; Tumor rejection

Indexed keywords

CD1D ANTIGEN; MESSENGER RNA; HLA ANTIGEN CLASS 1; XENOPUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; CANCER GRAFT; CANCER TRANSPLANTATION; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GENE SILENCING; HOST; IN VIVO STUDY; LEUKOCYTE; LYMPHATIC SYSTEM TUMOR; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TADPOLE; THYMOMA; TUMOR ESCAPE; TUMOR REJECTION; XENOPUS; XENOPUS NON CLASSICAL CLASS IB 10 GENE; ANIMAL; ENZYME IMMUNOASSAY; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; LARVA; LYMPHOID TISSUE; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; XENOPUS LAEVIS;

ANIMALS; BLOTTING, WESTERN; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOENZYME TECHNIQUES; LARVA; LYMPHOID TISSUE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYMUS NEOPLASMS; TUMOR ESCAPE; XENOPUS LAEVIS; XENOPUS PROTEINS;

EID: 84905674527     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu100     Document Type: Article

References (33)

1. Chang, C.C., et al. (2003) HLA class I defects in malignant lesions: what have we learned? The Keio journal of medicine, 52, 220-9.
2. Connor, M.E., et al. (1990) Loss of MHC class-I expression in cervical carcinomas. International journal of cancer. Journal international du cancer, 46, 1029-34.
3. Bukur, J., et al. (2012) The role of classical and non-classical HLA class I antigens in human tumors. Seminars in cancer biology, 22, 350-8
4. De Kruijf, E.M., et al. (2010) HLA-E and HLA-G expression in classical HLA class Inegative tumors is of prognostic value for clinical outcome of early breast cancer patients. Journal of immunology, 185, 7452-9.
5. Goncalves, M.A., et al. (2008) Classical and non-classical HLA molecules and p16(INK4a) expression in precursors lesions and invasive cervical cancer. European journal of obstetrics, gynecology, and reproductive biology, 141, 70-4.
6. Paul, P., et al. (1998) HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proceedings of the National Academy of Sciences of the United States of America, 95, 4510-5.
7. Gleimer, M., et al. (2003) Stress management: MHC class I and class I-like molecules as reporters of cellular stress. Immunity, 19, 469-77.
8. Ugurel, S., et al. (2001) Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy. Cancer, 92, 369-76.
9. Wolpert, F., et al. (2012) HLA-E contributes to an immune-inhibitory phenotype of glioblastoma stem-like cells. Journal of neuroimmunology, 250, 27-34.
10. Ishitani, A., et al. (2006) The involvement of HLA-E and -F in pregnancy. Journal of reproductive immunology, 69, 101-13.
11. Lepin, E.J., et al. (2000) Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors. European journal of immunology, 30, 3552-61.
12. Lin, A., et al. (2011) HLA-F expression is a prognostic factor in patients with non-smallcell lung cancer. Lung cancer, 74, 504-9.
13. Chiang, E.Y., et al. (2002) The nonclassical major histocompatibility complex molecule Qa-2 protects tumor cells from NK cell- and lymphokine-activated killer cell-mediated cytolysis. Journal of immunology, 168, 2200-11.
14. Goyos, A., et al. (2009) Novel nonclassical MHC class Ib genes associated with CD8 T cell development and thymic tumors. Molecular immunology, 46, 1775-86.
15. Flajnik, M.F., et al. (1993) A novel type of class I gene organization in vertebrates: a large family of non-MHC-linked class I genes is expressed at the RNA level in the amphibian Xenopus. The EMBO journal, 12, 4385-96.
16. Goyos, A., et al. (2007) Involvement of nonclassical MHC class Ib molecules in heat shock protein-mediated anti-tumor responses. European journal of immunology, 37, 1494-501.
17. Edholm, E.S., et al. (2013) Nonclassical MHC class I-dependent invariant T cells are evolutionarily conserved and prominent from early development in amphibians. Proceedings of the National Academy of Sciences of the United States of America, 110, 14342-7.
18. Goyos, A., et al. (2011) Remarkable conservation of distinct nonclassical MHC class I lineages in divergent amphibian species. Journal of immunology, 186, 372-81.
19. Robert, J., et al. (1994) Lymphoid tumors of Xenopus laevis with different capacities for growth in larvae and adults. Developmental immunology, 3, 297-307.
20. Du Pasquier, L., et al. (1992) In vitro growth of thymic tumor cell lines from Xenopus. Developmental immunology, 2, 295-307.
21. Robert, J., et al. (1997) Antibody cross-linking of the thymocyte-specific cell surface molecule CTX causes abnormal mitosis and multinucleation of tumor cells. Experimental cell research, 235, 227-37.
22. Fisher, T.L., et al. (2002) Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors. The Prostate, 51, 153-65.
23. Nedelkovska, H., et al. (2010) Comparative in vivo study of gp96 adjuvanticity in the frog Xenopus laevis. Journal of visualized experiments: JoVE.
24. Hallowes, R.C., et al. (1980) A new dimension in the culture of breast.
25. Morales, H.D., et al. (2010) Innate immune responses and permissiveness to ranavirus infection of peritoneal leukocytes in the frog Xenopus laevis. Journal of virology, 84, 4912-22.
26. Robert, J., et al. (1998) Ontogeny of CTX expression in xenopus. Developmental and comparative immunology, 22, 605-12.
27. Nedelkovska, H. (2012) Nonclassical MHC Class Ib Molecules: Critical Players in Tumor Immune Surveillance and Potential Immunotherapy Targets.
28. Wiendl, H., et al. (2002) A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. Journal of immunology, 168, 4772-80.
29. Robert, J., et al. (2001) Phylogenetic conservation of the molecular and immunological properties of the chaperones gp96 and hsp70. European journal of immunology, 31, 186- 95.
30. Hix, L.M., et al. (2011) CD1d-expressing breast cancer cells modulate NKT cellmediated antitumor immunity in a murine model of breast cancer metastasis. PloS one, 6, e20702.
31. Chiang, E.Y., et al. (2004) A nonclassical MHC class I molecule restricts CTL-mediated rejection of a syngeneic melanoma tumor. Journal of immunology, 173, 4394-401.
32. Pilones, K.A., et al. (2012) Invariant NKT cells as novel targets for immunotherapy in solid tumors. Clinical & developmental immunology, 2012, 720803.
33. Cui, J., et al. (1997) Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science, 278, 1623-6.